Products

Careverse CoronaryDoc (Careverse CoronaryDoc)
Careverse Technology Pte. Ltd.
Cardiology AI
Careverse CoronaryDoc is an AI-powered coronary CTA analysis tool that automatically identifies coronary arteries, detects stenosis, and characterizes plaques, enhancing workflow efficiency and supporting early intervention in coronary artery disease.

See all 1 product →

About Careverse Technology Pte.

Careverse Technology Pte. is a leading healthcare AI company focused on empowering a new era of smart healthcare through its AI-powered “Digital Doctor” platform. This platform is designed to assist human doctors in delivering more efficient, accurate, consistent, and accessible patient care. Careverse offers a comprehensive suite of over 40 AI-powered clinical applications that target critical therapeutic areas, including cardiovascular and cerebrovascular diseases, lung cancer, liver cancer, and breast cancer.

The company’s products cover various medical imaging modalities such as CT, MRI, ultrasound, X-rays, and mammography, aiming to reshape the entire workflow of disease management from screening and diagnosis to treatment decision-making and follow-up care. Careverse’s solutions have been adopted by thousands of hospitals globally and have obtained multiple certifications, including MDR CE markings and FDA 510(K) approvals. They also focus on integrating AI into the radiology workflow and providing diagnostic support.

Focus Areas

AI-powered medical imaging clinical decision support multimodal imaging AI large language models cardiovascular diseases cerebrovascular diseases lung cancer liver cancer breast cancer ultrasound AI+AR

Business Intelligence

TechnologyAI Operating System for All Care, Digital Body platform, multimodal imaging AI, large language models, AI+AR ultrasound system, cloud-native (implied by global reach and AI services)

What Physicians Need to Know

AI-Powered Medical Imaging
Careverse offers over 40 AI-powered clinical applications across multiple imaging modalities (CT, MRI, Ultrasound, X-ray, Mammography) for comprehensive disease management, from screening to treatment and follow-up. Their 'Digital Doctor' platform includes specialized suites like 'Digital Heart,' 'Digital Brain,' 'Digital Chest,' 'Digital Abdomen,' and 'Digital Breast' for various organs and diseases.
Clinical Decision Support
Their AI solutions are designed to assist human doctors in delivering more efficient, accurate, consistent, and accessible patient care. This includes automated analysis of complex imaging data, generating diagnostic suggestions, and pre-reports to reduce manual workload. Careverse's AI can also interpret and extract key information from reports, generate real-time reports, and assist with structured clinical documentation.
Multimodal Imaging AI
Careverse integrates AI across various imaging modalities (CT, MRI, Ultrasound, X-ray, Mammography) to provide a holistic view for diagnosis and treatment of conditions like cardiovascular and cerebrovascular diseases, and various cancers. Their 'Digital Heart' product family, for example, utilizes both CT and MR modalities for intelligent analysis of coronary arteries, vulnerable plaques, and heart function.
Large Language Models (LLMs)
Careverse has showcased innovations in multimodal large language models (MLLMs) trained on petabytes of big data. These LLMs excel in text processing (interpreting reports, generating real-time reports), image processing (auto-segmentation, detection, classification, cinematic rendering), and advanced interpretation for differential diagnoses.
Cardiovascular Diseases
The 'Digital Heart' suite offers fully automated coronary CAD-RADs and CT-FFR analysis, from image post-processing to reporting, in just 3 minutes. It also includes intelligent analysis of coronary vulnerable plaques, peri-coronary fat, and CT heart function, as well as coronary MRA AI and CMR AI products. Careverse's AI can analyze a single chest CT scan for early detection of heart disease.
Cerebrovascular Diseases
The 'Digital Brain' AI solution covers the entire stroke imaging procedure, including cerebral-CTA, CT perfusion, non-contrast CT analysis (ASPECTS Score, hemorrhage), and aneurysm detection. Their workflow for cerebrovascular applications can be completed in 3 minutes, encompassing post-processing, image interpretation, and reports.
Lung Cancer
The 'Digital Chest' suite provides early screening for multiple lung diseases and supports 3D surgical planning. Careverse's AI assists in lung nodule detection, aiding in early screening, diagnosis, and treatment of lung cancer.
Liver Cancer
The 'Digital Abdomen' suite offers AI-assisted diagnosis with LI-RADS standards for CT & MR liver imaging and advanced 3D surgical planning. Their solutions include automatic MR sequence differentiation, 3D reconstruction, and segmentation for the whole liver and vessels.
Breast Cancer
The 'Digital Breast' solutions empower the full patient journey from screening, diagnosis, treatment, to follow-ups, including MammographyDoc and BreastUsDoc Pro. Careverse's ultrasound AI+AR system is also used for breast imaging.
Ultrasound AI+AR
Careverse has introduced the world's first AI+AR ultrasound system, which analyzes ultrasound video streams in real-time and displays AI-enhanced lesion details directly on the original ultrasound screen. This technology assists doctors during scanning and diagnosis, significantly improving detection and diagnostic processes for conditions in areas such as breast, thyroid, carotid artery, and obstetrics.
Physician Tip

Careverse's 'Digital Doctor' platform acts as a 'Healthcare Copilot,' aiming to enhance efficiency, accuracy, consistency, and accessibility in patient care. Physicians can benefit from fully automated workflows, rapid analysis and reporting (e.g., 3-minute coronary analysis), and AI-enhanced lesion visualization in real-time during ultrasound scans. The platform's comprehensive coverage across multiple modalities and disease areas, combined with clinically validated accuracy, can significantly reduce manual workload and support more precise diagnostic and treatment decisions. Their large language models can also aid in documentation and information extraction, streamlining administrative tasks.

Careverse's products are designed for integration into existing radiology workflows and can be deployed locally within hospital intranets to maintain data privacy. They offer an integrated, safe, and convenient 'Digital Doctor Platform' solution. Careverse also emphasizes collaboration with top research institutions and hospitals globally, indicating a focus on interoperability and real-world clinical application.

Products by Careverse Technology Pte.

1 product in the directory

Careverse CoronaryDoc (Careverse CoronaryDoc)
Careverse Technology Pte. Ltd.
Cardiology AI
Careverse CoronaryDoc is an AI-powered coronary CTA analysis tool that automatically identifies coronary arteries, detects stenosis, and characterizes plaques, enhancing workflow efficiency and supporting early intervention in coronary artery disease.

What the Web Says

Information on "Careverse Technology Pte." is limited and often conflated with other companies containing "Care" in their name. While some sources mention their product "Careverse CoronaryDoc" as a web-based tool for reanalysis turnaround and analyst correction audit processes, there are no direct product or employer reviews available from the requested platforms (G2, Glassdoor, Capterra, Reddit) for "Careverse Technology Pte." specifically. There are mentions of a related entity, "MEDIQRY (Careverse Technologies Pvt. Ltd.)" being recognized as a healthcare technology startup by the Government of India.

Overall: Mixed

Limitations

No significant limitations found in public reviews. Consider checking vendor documentation or requesting a demo for a thorough evaluation.

Based on reviews from: Google Search

Last updated: 2026-10-21

Videos

News, demos, and interviews about Careverse Technology Pte..

Loading videos...

Videos load interactively. If none appear, search YouTube for Careverse Technology Pte. →

View all on YouTube

Press & Coverage

FDA
K251656 - 510(k) Premarket Notification - FDA
Careverse Technology Pte. Ltd. received a Substantially Equivalent (SESE) decision from the FDA for their device under regulation number 892.205023 on September 4, 2025.
2025-09
Innolitics
2025 Year in Review: Cardiology AI/ML SaMD 510(k) Clearances - Innolitics
Careverse Technology Pte. Ltd.'s 'Careverse CoronaryDoc' received a Traditional 510(k) clearance in October 2025, as part of a comprehensive analysis of 2025 cardiology AI/ML clearances.
2026-01
PR Newswire APAC
CAREVERSE TECHNOLOGY PTE.LTD. Mediaroom - PR Newswire APAC
Careverse Technology Pte. Ltd. highlighted their presence at RSNA 2024, leading new trends in medical AI.
2024-12
FDA
TPLC - Total Product Life Cycle - FDA
Careverse Technology Pte. Ltd. is listed on the FDA's Total Product Life Cycle database as having a 'Substantially Equivalent' status.
2026-10
RecordOwl
CAREVERSE TECHNOLOGY PTE. LTD. (202239792R) - RecordOwl
Careverse Technology Pte. Ltd. is a Singapore-based health technology company incorporated in November 2022, focusing on AI-powered solutions for medical imaging and clinical decision support, with an estimated annual revenue of approximately $598,885 and no external funding.
2026-08
Trade Show Contacts
ACC Scientific Session 2026 Exhibitor List
Careverse Technology Pte. Ltd. is listed as an exhibitor at the ACC Scientific Session 2026.
2026-03
BINASSS
Artificial intelligence denoising in cardiac photon-counting CT - BINASSS
Careverse Technology Pte. Ltd. is mentioned in a peer-reviewed article for their AI-powered software used to extract CAD-RADS scores and plaque characteristics from cardiac CT images.
2026-05

Frequently Asked Questions

Careverse Technology Pte. offers a comprehensive 'Digital Doctor' platform with over 40 AI-powered clinical applications across multiple imaging modalities. For cardiovascular diseases, they have 'Digital Heart' products like CoronaryDoc, FFR, and CacScoreDoc. For cerebrovascular diseases, their 'Digital Brain' suite includes CerebralGo Plus, PerfusionGo Plus, and StrokeDoc. For lung cancer, they offer LungDoc and solutions for early screening. For liver cancer, they provide LiverMRDoc and AI-assisted diagnosis with LI-RADS standards. For breast cancer, they offer MammographyDoc and BreastUsDoc Pro.
Careverse Technology Pte. prioritizes compliance and has obtained 12 MDR CE markings, 2 FDA 510(K) approvals, and 1 PMDA Certificate for its products. They have also received UKCA and Class III NMPA clearances for various applications within their 'Digital Doctor' platform.
Careverse Technology Pte. collaborates with top research institutions in Japan, Southeast Asia, the US, and Europe. They have also formed a critical research partnership with the Diagnostikum Group, focusing on FFR-CT for coronary ischemia and liver MR AI for tumor malignancy and surgical planning.
Careverse Technology Pte. is actively integrating multimodal imaging AI and large language models into their solutions. Their 'Digital Heart' platform, for example, leverages multimodal workflow for cardiac images, and their AI system can analyze real-time ultrasound video streams, displaying AI-enhanced lesion details directly on the screen.
Careverse Technology Pte. has introduced an AI+AR ultrasound system that analyzes scans in real-time, overlaying AI-detected lesions directly onto the ultrasound screen with high precision. This technology assists doctors during scanning and diagnosis, significantly improving detection and diagnostic processes for conditions in areas such as breast, thyroid, carotid artery, and obstetrics. While the benefits include enhanced efficiency and accuracy, potential concerns for implementation could involve integration with existing ultrasound equipment and ensuring user-friendliness for physicians.

Related Companies

Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]

SOPHiA GENETICS is a healthcare AI company that has developed a cloud-native, AI-driven SaaS platform called SOPHiA DDM™. This platform is designed to enable hospitals, clinical laboratories, academic medical centers, and biopharmaceutical companies to analyze and interpret complex genomic, radiomic, and multimodal healthcare data. The company’s mission is to democratize data-driven medicine, providing actionable insights […]

Qure.ai is a leading healthcare AI company that leverages deep learning and artificial intelligence to revolutionize medical imaging diagnostics and make healthcare more accessible and affordable globally. The company develops AI-powered solutions for interpreting X-rays and CT scans, addressing critical health needs in areas such as lung, musculoskeletal, cardiovascular, and neurocritical health. Their technology assists […]

Deep Bio is a healthcare AI company that develops deep learning-based cancer diagnostic support software, aiming to advance patient outcomes by empowering clinicians with innovative technology. Their mission is to provide tools that enable medical professionals to make critical decisions, ultimately enhancing healthcare delivery and allowing clinicians to focus more on patient care. The company’s […]

CortiCare is a healthcare AI company specializing in neuro telemetry and remote patient monitoring, primarily focusing on electroencephalogram (EEG) services. The company provides telehealth services and an EEG brain monitoring platform to neurology and critical care areas within hospitals, including ICUs, NICUs, PICUs, and EMUs. Their services aim to enhance the neurological assessment of adult, […]

CapsoVision is a commercial-stage medical technology company that develops advanced imaging and artificial intelligence (AI) technologies for capsule endoscopy solutions. Their primary goal is to identify abnormalities of the gastrointestinal (GI) tract for diagnostic and screening purposes. [7] Their flagship product, the CapsoCam Plus system, is a single-use capsule endoscope equipped with four cameras, providing […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.